Vagus Nerve Stimulation

This is the book the popular titles are ultimately answerable to. Where Tracey tells the story and Habib gives you protocols, this multi-author Elsevier volume is the field's current clinical map — the reference a neurologist or researcher opens when they need the actual state of the evidence rather than the narrative around it.

Its value is breadth handled by specialists. Rather than one author's throughline, it assembles contributors across the indications where VNS is used or under study — epilepsy (its oldest and best-established use), treatment-resistant depression, inflammatory disease, and newer frontiers like acute stroke, headache, and cardiometabolic conditions — each written by people running the work. It covers both implanted (iVNS) and non-invasive (taVNS, tcVNS) approaches, and it doesn't flinch from the parts that are still uncertain: mechanism gaps, dosing questions, mixed trial results.

That honesty is the point. A clinical reference earns trust precisely by refusing to oversell, and this one reads as a snapshot of a field mid-development rather than a finished story. It is the sober counterweight to the optimism of the trade books.

The fair caveats are what you'd expect of a specialist volume: it is expensive, technical, and written for clinicians, not curious lay readers — dense with trial detail and terminology. And like any edited reference in a fast-moving area, it is a snapshot; as trials report out, parts will date. It informs decisions; it isn't a bedside read.

On this shelf: the rigorous anchor. If The Great Nerve is the invitation, this is the fine print. Pair it with the study-level evidence on this site — many of the trials it discusses are individually catalogued in the condition hubs — to move from summary to source.

Best for: clinicians, researchers, and serious readers who want the comprehensive, caveated clinical picture rather than the popular version.